when did semaglutide hit the market 💊 GLP-1 Explosion: From ₹1,446 Cr to ₹10,000+ Cr Opportunity Generic launches just India—and numbers are staggering. February 2026 saw GLP-1 sales surge 177% YoY to ₹1,446 crore Wegovy (Semaglutide) - Semaglutide market

Det er en spndende tid for peptidforskning inden for omrderne fedme og metabolisk sundhed og interessen for Retatrutide eksploderer forventeligt

Semaglutide, a cornerstone in the treatment of type 2 diabetes and obesity, and ibuprofen, a widely utilized analgesic and anti-inflammatory agent, have distinct therapeutic benefits

The FDA has also received hundreds of reports of suicidal ideation in patients taking these drugs

Lilly tambin seal que la seguridad del medicamento no ha sido determinada durante el embarazo, y que las personas que toman pldoras anticonceptivas deben consultar con su mdico sobre la posibilidad de usar otro mtodo, ya que podran ser menos efectivas mientras se toma Foundayo

Help for the toughest cases For one thing, doctors generally only prescribe weight-loss drugs to people who are obese with a BMI of at least 30, or overweight with a BMI of at least 27, and have high-blood pressure and other weight-related conditions